ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options - Kiladjianm, Jean-Jacques; Marin, Francisca Ferrer; Al-Ali, Haifa Kathrin; Alvarez-Larrán, Alberto; Beggiato, Eloise; Bieniaszewska, Maria; Breccia, Massimo; Buxhofer-Ausch, Veronika; Cerna, Olga; Crisan, Ana-Manuela; Reiter, Andreas (Annals of hematology, 2024)
Gesehen am 15.10.2024